Family Management Corp Regeneron Pharmaceuticals, Inc. Transaction History

Family Management Corp

$553 Million
Q2 2024

A detailed history of Family Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Family Management Corp holds 6,650 shares of REGN stock, worth $6.99 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

6,650

Previous 6,276 5.96%

Holding current value

$6.99 Million

Previous $6.04 Million 15.71%

% of portfolio

1.26%

Previous 1.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $330,316 - $400,625	374 Added 5.96%	6,650 $6.99 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $520,852 - $573,162	577 Added 10.12%	6,276 $6.04 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $343,404 - $390,593	-443 Reduced 7.21%	5,699 $5.01 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $43,624 - $53,195	-63 Reduced 1.02%	6,142 $5.05 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $60,202 - $71,410	-86 Reduced 1.37%	6,205 $4.46 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $217,756 - $264,630	320 Added 5.36%	6,291 $5.17 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $45,882 - $49,815	-65 Reduced 1.08%	5,971 $4.31 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $37,882 - $47,805	-66 Reduced 1.08%	6,036 $4.16 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $147,506 - $198,747	-269 Reduced 4.22%	6,102 $3.61 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $7,736 - $9,079	-13 Reduced 0.2%	6,371 $4.45 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $64,674 - $79,845	119 Added 1.9%	6,384 $4.03 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $35,015 - $41,538	61 Added 0.98%	6,265 $3.79 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $417,009 - $492,632	-882 Reduced 12.45%	6,204 $3.47 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $28,143 - $34,536	63 Added 0.9%	7,086 $3.35 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $859,026 - $1.09 Million	1,796 Added 34.36%	7,023 $3.39 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $793,700 - $959,011	-1,457 Reduced 21.8%	5,227 $2.93 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $947,174 - $1.24 Million	-1,920 Reduced 22.32%	6,684 $4.17 Million
Q1 2020 May 06, 2020	SELL	$336.18 - $494.43 $37,652 - $55,376	-112 Reduced 1.28%	8,604 $4.2 Million
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $3,837 - $5,271	-14 Reduced 0.16%	8,716 $3.27 Million
Q3 2019 Nov 15, 2019	BUY	$273.46 - $318.39 $16,681 - $19,421	61 Added 0.7%	8,730 $2.42 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $18,595 - $21,650	-68 Reduced 0.78%	8,669 $2.41 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $40,146 - $55,585	134 Added 1.56%	8,737 $2.74 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $1.52 Million - $1.8 Million	4,087 Added 90.5%	8,603 $3.53 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.52 Million - $1.82 Million	4,516 New	4,516 $1.69 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.

Account

Family Management Corp Regeneron Pharmaceuticals, Inc. Transaction History